WT1 methylation was associated with breast cancer risk both in multivariable and PS adjusted methods with ORs of 2.42 (95% CI: 1.45–4.04, P < 0.01) and 3.07 (95% CI: 1.67–5.64, P < 0.01), respectively. This evidence concerns the gene WT1 and breast cancer.